• U.S. Supreme Court Finds Human Genes Patent Ineligible: Association for Molecular Pathology, Inc. v. Myriad Genetics, Inc.
  • November 27, 2013
  • Law Firm: Staas Halsey LLP - Washington Office
  • On June 13, 2013, the United States Supreme Court (the "Court") decided an important case involving patent eligible subject matter in Association for Molecular Pathology, Inc. v. Myriad Genetics, Inc. By a vote of 9-0, the Court held that human genes are not eligible for patents. However, the Court also held by the same vote that synthetic DNA, also known as cDNA, could be patent eligible under certain circumstances.